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The nucleolus is a dynamic nuclear body that has been demonstrated to disassemble at the onset of mitosis; the
relationship between cell cycle progression and nucleolar integrity, however, remains poorly understood. We studied
the role of nucleolar proteins in mitosis by performing a global analysis using small interfering RNAs specific to nu-
cleolar proteins; we focused on nucleolar protein 11 (NOL11), with currently unknownmitotic functions. Depletion of
NOL11 delayed entry into the mitotic phase owing to increased inhibitory phosphorylation of cyclin-dependent
kinase 1 (Cdk1) and aberrant accumulation of Wee1, a kinase that phosphorylates and inhibits Cdk1. In addition to
effects on overall mitotic phenotypes, NOL11 depletion reduced ribosomal RNA (rRNA) levels and caused nucleolar
disruption during interphase. Notably, mitotic phenotypes found in NOL11-depleted cells were recapitulated when
nucleolar disruptionwas induced by depletion of rRNA transcription factors or treatmentwith actinomycinD. Further-
more, delayed entry into themitotic phase, causedby the depletion of pre-rRNA transcription factors, was attributable
to nucleolar disruption rather than to G2/M checkpoint activation or reduced protein synthesis. Our findings therefore
suggest that maintenance of nucleolar integrity during interphase is essential for proper cell cycle progression to
mitosis via the regulation of Wee1 and Cdk1.ed f
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 INTRODUCTION
The nucleolus is the largest nuclear body, and its structure changes dy-
namically in higher eukaryotes. The canonical function of the nucleolus
is to serve as the site for ribosome biogenesis. The nucleolus forms
around clusters of tandemly repeated ribosomal DNA (rDNA), where
RNA polymerase I (Pol I) transcribes the rDNA repeats and generates
47S rRNAs (pre-rRNAs). The initially transcribed pre-rRNAs undergo
processing to form mature 28S, 18S, and 5.8S rRNAs, which are
assembledwith ribosomal proteins to generate ribosomes (1). Nucleolar
structure is governed by RNA levels within the nucleolus because pre-
rRNAs and/or intermediate rRNAs form the scaffold for nucleolar pro-
teins (2). Inhibition of rRNA transcription reduces the total rRNA levels
within the nucleolus, thereby altering the architecture and composition
of the nucleolus. In response to inhibition of rRNA transcription, some
nucleolar proteins form a nucleolar cap at the nucleolar periphery, and
some of the proteins translocate to the nucleoplasm—this is known as
nucleolar disruption (3, 4). On the other hand, loss of rRNA processing
increases nucleolar RNA levels owing to the accumulation of pre-
rRNAs or intermediate rRNAswithin the nucleolus, leading to enlarge-
ment of the nucleolus (5).
Recent studies have shown that cellular stress and nucleolar integrity
are closely linked. Various types of intra- or extracellular stimuli de-
crease rRNA transcription, which in turn translocates nucleolar pro-
teins to the nucleoplasm (6). The translocated nucleolar proteins
induce stress-response events such as p53 activation (7), autophagy
(8, 9), and cell differentiation (10, 11). Thus, the nucleolus may coor-
dinate stress response by altering its architecture and composition.
The nucleolus is tightly connected to cell cycle progression. During
interphase, the enzymes involved in posttranslational modificationssuch as ubiquitination, sumoylation, and phosphorylation are pre-
dominantly localized in the nucleolus (1). Therefore, it is possible that
translocation of these enzymes in response to altered nucleolar struc-
ture would influence cell cycle progression. The most well-characterized
examples of such enzymes areCdc14B (12) andPP1g (13), both ofwhich
respectively regulate G2/M checkpoint and chromosome segregation, in
that they are sequestrated to the nucleolus and released to function at a
proper time during the cell cycle. At the onset of mitosis, rRNA tran-
scription is suppressed by cyclin-dependent kinase 1 (Cdk1) activation,
leading to the disassembly of the nucleolus. When cells exit mitosis and
Cdk1 is inactivated, rRNA transcription resumes and the nucleolus is
reassembled. As the nucleolus is disassembled duringmitosis,many nu-
cleolar proteins translocate to the cytoplasm, a phenomenon that is sim-
ilar to nucleolar disruption during interphase. A previous study used
comprehensive proteome analysis to classify the molecular function
of 700 nucleolar proteins and showed that some nucleolar proteins
are involved in cell cycle control as well as DNA replication and repair
(14). Therefore, it is reasonable to assume that some of the nucleolar
proteins influence cell cycle progression by regulating cell cycle events
and/or by changing their localization during mitosis.
Here, we performed a nucleolar RNA interference screen and found
that nucleolar protein 11 (NOL11) controlled mitotic progression. De-
pletion of NOL11 also reduced rRNA transcription and nucleolar dis-
ruption during interphase. In particular, we found that the mitotic
phenotypes were recapitulated when nucleolar disruption was induced
by the depletion of other rRNA transcription factors. Our results
showed that the temporal coordination between the cell cycle and nu-
cleolar integrity is crucial for the proper progression of mitosis.RESULTS
NOL11 depletion delays mitotic entry by inhibiting
Cdk1 activation via abnormal Wee1 accumulation
Recent studies suggested that the nucleolus has multiple functions, in-
cluding regulation of mitosis (15–17). We performed a large-scale
screen with small interfering RNAs (siRNAs) against mRNAs encoding
591 nucleolar proteins (14) to identify nucleolar proteins whose1 of 11
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59 candidate proteins (table S1), we focused on NOL11, whose mitotic
function remained unknown.
First, we ascertained whether NOL11 was localized in the nucleolus,
using HeLa cells stably expressing FLAG- and hemagglutinin-tagged
NOL11. The nucleolus consists of three distinct compartments: the fi-
brillar center (FC), the dense fibrillar component (DFC), and the gran-
ular component (GC), each having a unique protein composition (fig.
S1A). NOL11 largely colocalized with FBL and MYBBP1A, both of
which are DFC markers (fig. S1B, middle). NOL11 also partially co-
localized with UBF, an FCmarker, but was excluded from the UBF foci
within the nucleolus (fig. S1B, top) and slightly overlapped with nucleo-
lin and NPM, which are GC markers (fig. S1B, bottom). These results
showed that NOL11 predominantly localized in the DFC region within
the nucleolus.
Next, we tested the effect of NOL11 depletion by using two different
siRNAs specific to NOL11 (Fig. 1A). We found that NOL11 depletion
increased the population of mitotic cells in asynchronous cultures (fig.
S2A), which was in accordance with the screen results. To further an-
alyze the effect of NOL11 depletion on cell cycle progression, we syn-
chronized HeLa cells at the G1/S phase by thymidine blocking after
NOL11depletion.NOL11depletion hadnegligible influence on the pro-Hayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018gression of the cells from2N (G1 phase) to 4N (G2/Mphase; Fig. 1B, 0 to
9 hours); however, it arrested the cell cycle with respect to the 4N cell
population (Fig. 1B, 10.5 and 12 hours). Most of the control cells exited
mitosis and entered theG1 phase by 12 hours after the release fromG1/S
synchronization, whereas most of the NOL11-depleted cells remained
in theG2/Mphase. To analyze cell cycle progression in further detail, we
performed dual-color analysis with fluorescence-activated cell sorting
(FACS), using propidium iodide (PI) staining in combination with anti–
cyclin B1, anti-MPM2, and anti–H3-pS10 antibodies. This method re-
vealed that NOL11 depletion delayed the accumulation of H3-pS10, a
hallmark of mitosis (Fig. 1C, blue line). The fluctuation pattern of the
MPM2 epitopes (Fig. 1C, gray line), which showed phosphorylated
Cdk1 substrates and was indicative of mitosis, was similar to that of
H3-pS10. In particular, NOL11 depletion did not affect the accumula-
tion of cyclin B1 at the onset ofmitosis (Fig. 1C, orange line).Nine hours
after the release fromG1/S synchronization, cyclin B1 accumulated nor-
mally; however, MPM2 epitopes were low inNOL11-depleted cells.We
therefore assumed that NOL11 depletion delayed mitotic entry by sup-
pressing Cdk1 activation without affecting cyclin B1 expression.
We then synchronized the cells at the G2/M border using RO-3306,
a potent Cdk1 inhibitor (18), and repeated the dual-color FACS
experiments using anti-MPM2 antibodies to precisely examine the o
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 Fig. 1. NOL11 depletion delayed mitotic entry irrespective of proper accumulation of cyclin B1. (A) The efficiency of NOL11 depletion using siRNA against NOL11.
HeLa cells were transfected with luciferase siRNA (siCont.) or two distinct NOL11-specific siRNAs (siNOL11 #1 and #2). Forty-eight hours after transfection, whole-cell
extracts were immunoblotted using the indicated antibodies. A dilution series of cell extracts from control cells (siCont.; lanes 1 to 5; 100, 50, 25, 12.5, and 6.3%,
respectively) were performed simultaneously to estimate depletion efficiency. b-Actin was used as a loading control. (B) Arrest at the G2/M phase in NOL11-depleted
cells. HeLa cells transfected with the indicated siRNAs were synchronized to the G1/S phase. After release from the thymidine block, the cells were collected at the
indicated times, and the cell cycle distribution was measured by FACS using PI. (C) Delayed mitotic entry in NOL11-depleted cells. The top panel shows the scheme for
siRNA treatment and cell cycle synchronization by double thymidine block. HeLa cells released from the G1/S phase were collected at the indicated times after release.
The collected cells were divided into three aliquots, and each aliquot was analyzed by dual-color FACS using a combination of PI and anti–cyclin B1, anti-MPM2, or anti–
H3-pS10 antibodies. The populations of 4N–cyclin B1+ cells, 4N-MPM2+ cells, and 4N–H3-pS10+ cells are indicated as colored squares in the representative plots (right
panels). Line graphs indicate the percentage of these populations at the indicated time (lower left graphs). Values are shown as the means ± SD, n = 3.2 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L EG2-M transition. At the G2/M border, the number of MPM2-positive
cells was very low in control and NOL11-depleted cells. In control cells,
removal of RO-3306 led to a rapid increase in the number of MPM2-
positive cells, the proportion of which reached about 50% at 1 hour after
release from the G2/M border. The number of MPM2-positive control
cells gradually decreased 3 hours after release and returned to pre–RO-
3306–removal levels (Fig. 2A). In contrast, in NOL11-depleted cells,
MPM2-positive cells slowly increased in number over a period of
6 hours after release from the G2/M border (Fig. 2A), suggesting that
Cdk1 activation is impaired by NOL11 depletion.
Cdk1 activity is regulated by removal of inhibitory phosphorylation
of Cdk1 in addition to increased cyclin B expression. To examine the
phosphorylation status of Cdk1 during the G2-M transition, we per-Hayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018formed immunoblotting after synchronization at the G2/M border.
When the cells were released from the G2/M border, cyclin B1 levels
in control cells gradually decreased in a time-dependentmanner, which
is indicative of normal cell cycle progression (Fig. 2B). Cdk1 phospho-
rylation at Tyr15 (Cdk1-pY15) was very low or hardly detectable in
control cells. NOL11-depleted cells, by contrast, showed substantially
increased Cdk1-pY15 levels at the G2/M border, and there was no
apparent difference in cyclin B1 levels before release. Furthermore,
Cdk1-pY15 signals persisted even after removing RO-3306 in NOL11-
depleted cells.
Nuclear translocation of cyclin B is required for the rapid activation
of Cdk1 and subsequent key mitotic events such as nuclear envelop
breakdown (NEBD) and chromosome condensation (19). Therefore, o
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 Fig. 2. NOL11 depletion impaired Cdk1 activation. (A) Delayed Cdk1 activation after release from the G2/M border in NOL11-depleted cells. 4N-MPM2
+ cells were
identified by dual-color FACS. siRNA-treated HeLa cells synchronized at the G2/M border were released from the block and collected at the indicated times. Colored
squares show 4N-MPM2+ cells in the representative plots at 6 hours after release (left panels). The right graph shows the percentage of 4N-MPM2+ cells at the indicated
times after release from the G2/M border. Values are expressed as means ± SD, n = 3. (B) Increased Cdk1-pY15 in NOL11-depleted cells. Cells were synchronized and
collected as shown in (A). The whole-cell extracts were immunoblotted with the indicated antibodies. (C) Delayed nuclear translocation of cyclin B1 and NEBD in
NOL11-depleted cells. HeLa cells were released from RO-3306 synchronization. At the indicated times, cells were fixed and stained with anti–cyclin B1 antibody (green)
and 4′,6-diamidino-2-phenylindole (DAPI) (blue). Arrows and arrowheads indicate cyclin B1 translocated into the nucleus and cells with NEBD, respectively. Scale bars,
10 mm. The percentage of cyclin B1 translocated into the nucleus (upper right graph) and NEBD (lower right graph) is shown. Over 200 cells were counted at each time
point for each siRNA.3 of 11
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 we examined the subcellular localization of cyclin B1 during the G2-M
transition. In both control and NOL11-depleted cells synchronized at
the G2/M border with RO-3306, cyclin B1 signals in the nucleus were
barely detectable (Fig. 2C, 0 min). Removal of RO-3306 caused rapid
cyclin B1 translocation from the cytoplasm to the nucleus in control
cells, nearly 70% of which showed nuclear staining of cyclin B1 at
10 min and over 80% showed staining at 60 min. In contrast, NOL11
depletion severely delayed nuclear accumulation of cyclin B1; the num-
ber of cells showing cyclin B1 accumulation in the nucleus at 60 min
was markedly lower than that of control cells at 10 min. Along with
translocation of cyclin B1 into the nucleus, NEBD was also delayed in
NOL11-depleted cells, indicating that cyclin B1 translocation and sub-
sequent mitotic events were severely inhibited in NOL11-depleted
cells. It is thus clear that suppression of Cdk1 activity and delayed mi-
totic entry were caused by both increased Cdk1-pY15 levels and
blocking of cyclin B1 nuclear translocation in NOL11-depleted cells.
We next examined how NOL11 depletion delayed Cdk1 activation.
Cdk1-pY15 is regulated by the balance between kinases, such as Wee1
and Myt1, and Cdc25 phosphatases (20). Although the functions of
Myt1 remain unclear, Wee1 has been shown to play a critical role in
controlling the G2-M transition based on experiments using Wee1-
specific inhibitors, siRNA-mediatedWee1 depletion, andWee1 knock-
out mice (21–23). During G2-M transition, Wee1 kinase undergoes
ubiquitin-mediated degradation, while Cdc25 is activated, tilting the
balance toward Tyr15 dephosphorylation and Cdk1 activation. Using
RO-3306 synchronization, we checked the levels of Wee1 and Cdc25
at theG2/Mborder. TheNOL11-depleted cells showed abnormally high
levels of Wee1, along with increased Cdk1-pY15 (Fig. 3A). In contrast,
levels of Cdc25 phosphatases changed only slightly following NOL11
depletion, if at all (Fig. 3A). These results suggest that accumulation
of Wee1 is the cause of delayed Cdk1 activation and mitotic entry
following NOL11 depletion. To examine fluctuation in the levels of
Wee1 proteins during the cell cycle, we examined the levels of Wee1
after release from G1/S synchronization in the presence of RO-
3306 to prevent mitotic entry. Wee1 levels gradually decreased in
control cells but remained relatively stable in the NOL11-depletedHayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018
ober 14, 2018cells (Fig. 3B), indicating thatWee1 was improperly stabilized during
cell cycle progression in the NOL11-depleted cells.
NOL11 depletion causes nucleolar disruption
In addition to the occurrence of mitotic phenotypes, NOL11 depletion
also down-regulated rRNA transcription (fig. S2, B and C), which is
consistent with previously published findings (24, 25). Inhibition of
rRNA transcription reportedly causes nucleolar disruption (3, 4), which
is accompanied by two typical phenotypes: translocation of the nucle-
olar proteins to the nucleoplasm and formation of a nucleolar cap at the
nucleolar periphery. To test whether NOL11 depletion causes nucleolar
disruption, we examined the effect of NOL11 depletion on the localiza-
tion of the nucleolar proteins by using siRNA for TIF-IA, an essential
Pol I transcription factor, as a positive control for nucleolar disruption.
NOL11depletion induced the translocation of nucleolin andMYBBP1A
into the nucleoplasm and the formation of nucleolar caps of UBF (fig.
S2D), which was similar to the effects of TIF-IA depletion (fig. S2D),
indicating that NOL11 depletion caused nucleolar disruption. An
alternative possibility is that NOL11 depletion influenced mitotic pro-
gression, which in turn caused nucleolar phenotypes during interphase.
However, this is unlikely because nucleolar disruption was induced de-
spite NOL11 depletion without passing through the mitotic phase (fig.
S3).We testedwhether 59 siRNAs (table S1) that increasedmitotic pop-
ulation in asynchronous cultures also caused nucleolar disruption dur-
ing interphase (fig. S4).However, judging from the area of nucleolin and
MYBBP1A in the nucleolus, nucleolar disruption was induced only by
siNOL11 treatment (fig. S4).
Nucleolar disruption is accompanied by delayed
mitotic entry
Previous reports have shown that nucleolar disruption induces a variety
of cellular events such as p53-dependent cell cycle arrest and apoptosis,
cell differentiation, and autophagy (7, 9, 11). Given that altered nucle-
olar morphology is involved in a variety of cellular events, it is possible
that nucleolar disruption during interphase was themain cause of delay
in the subsequent mitotic entry when NOL11 was depleted.
To test this hypothesis, we examinedwhether depletion of TIF-IA or
UBF, both of which induced nucleolar disruption (Fig. 4A), also delayed
mitotic entry. First, we tested cell cycle progression from G1/S synchro-
nization, after the depletion of TIF-IA or UBF, using dual-color FACS
analysis in combinationwithPI and anti–H3-pS10.Depletion of TIF-IA
or UBF delayed mitotic entry, akin to NOL11 depletion (Fig. 4B). Fur-
thermore, TIF-IA or UBF depletion strongly increased Cdk1-pY15
levels at all time points after the release from RO-3306 synchronization
(Fig. 4C), in amanner similar to that followingNOL11depletion (Fig. 2B).
In addition, nuclear accumulation of cyclin B1 was compromised by
TIF-IA or UBF depletion (Fig. 4D). Then, we tested whether similar
phenotypes were observed when nucleolar disruption was induced after
treatment with low-dose actinomycin D (Act D) instead of siRNAs (fig.
S5A). We found that Act D treatment also delayed mitotic entry, in-
creased Cdk1-pY15 levels, and impaired nuclear accumulation of cyclin
B1, in a similar way to the effects of NOL11, TIF-IA, or UBF depletion
(fig. S5, B to D). These results support our hypothesis that nucleolar
disruption during interphase causes delayed mitotic entry by inhibiting
Cdk1 activation.
We then tested how nucleolar disruption increased Cdk1-pY15
levels. We found that Wee1 accumulation was the cause of increased
Cdk1-pY15 levels in the NOL11-depleted cells, which showed a dis-
rupted nucleolus during interphase. Therefore, we conducted similarFig. 3. NOL11 depletion caused accumulation of Wee1. (A) Increased Wee1
levels caused by NOL11 depletion. HeLa cells were treated with the siRNAs for
NOL11 and synchronized at theG2/Mborder.Whole-cell extractswere immunoblotted
with the indicated antibodies. (B) Reduced Wee1 turnover by NOL11 depletion.
NOL11-depleted cells were synchronized by single thymidine block. Six hours after
release, cells were treated with 10 mM RO-3306 and collected at the indicated times
for immunoblotting. The number in the upper immunoblot panels shows hours after
the treatment of RO-3306.4 of 11
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 sets of the experiments as those shown in Fig. 3 (A and B) and checked
the levels of Wee1 and Cdc25 following depletion of TIF-IA or UBF
(Fig. 5, A and B). When cells were synchronized at the G2/M border
using RO-3306, cells with nucleolar disruption caused by the depletion
of TIF-IA or UBF contained high levels of Wee1, along with increased
Cdk1-pY15 levels (Fig. 5A). In contrast, levels of Cdc25 phosphatases
changed only slightly following TIF-IA or UBF depletion, and these
changeswere inconsistent for different siRNAs (Fig. 5A).When cellswere
released from G1/S synchronization in the presence of RO-3306, Wee1
levels gradually decreased in the control cells, but remained relativelyHayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018stable in TIF-IA or UBF-depleted cells (Fig. 5B). Act D treatment also
increasedWee1 levels at the G2/M border (fig. S5C). These results were
in accordancewith those ofNOL11depletion (Fig. 3, A and B), indicating
thatWee1was improperly stabilized during cell cycle progression in the
cells whose nucleoli were disrupted.
To confirm that accumulation of Wee1 is the leading cause of ab-
normal Cdk1 phosphorylation and delayed mitotic entry, we treated
cells withMK1775, an inhibitor ofWee1 kinase (26), at a concentration
of 100 nM, at which cell cycle progression remains almost intact in con-
trol cells (fig. S6A). Treatment of MK1775 improved the abnormalFig. 4. Nucleolar disruption by TIF-IA or UBF depletion also delayed mitotic entry. (A) Nucleolar disruption caused by TIF-IA or UBF depletion in addition to NOL11
depletion. HeLa cells were transfected with the indicated siRNAs and cultured for 48 hours. The cells were stained for immunofluorescence with anti-nucleolin antibodies
(green). DNAwas counterstained by DAPI (blue). Scale bars, 5 mm. (B) Delayedmitotic entry in cells with the disrupted nucleolus. HeLa cells were treated with the indicated
siRNAs and synchronized at the G1/S boundary by double thymidine as shown in Fig. 1C. Nine, 10.5, and 12 hours after release from G1/S synchronization, the cells were
collected for analysis of mitotic index by FACS. Upper histograms showed the results of TIF-IA or UBF depletion. Bottom histograms showed the results of NOL11 depletion,
which is from the result in Fig. 1C. Values are shown as means ± SD, n = 3. (C) Increased Cdk1-pY15 in cells with the disrupted nucleolus. HeLa cells were treated with the
indicated siRNAs and released from the G2/M border as the same protocol shown in Fig. 2A. The whole-cell extracts from the collected cells at the indicated times were
immunoblotted with the indicated antibodies. (D) Delayed nuclear translocation of cyclin B in cells with the disrupted nucleolus. HeLa cells were transfected with the
indicated siRNAs. The percentage of the cells in which cyclin B1 translocated into the nucleus is shown. Upper histograms showed the results of TIF-IA or UBF depletion.
Bottom histograms showed the results of NOL11, which is from the result in Fig. 2C. Over 200 cells were counted at each time point for each siRNA.5 of 11
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 phosphorylation of Cdk1 caused by depletion of NOL11, TIF-IA, or
UBFwithout affectingWee1 levels (Fig. 5C and fig. S6B).We also found
that nuclear translocation of cyclin B1, which was delayed by NOL11,
TIF-IA, or UBF depletion, was restored in the presence ofMK1775 (fig.
S6, C and D). Furthermore, treatment with MK1775 substantially sup-
pressed the inhibited mitotic entry elicited by NOL11, TIF-IA, or UBF
depletion (Fig. 5D). This finding suggests that the accumulation of
Wee1 in the cells with nucleolar disruption is the leading cause of ab-
normal Cdk1 phosphorylation and delayed mitotic entry.
Nucleolar disruption is the main reason for delayed
mitotic entry
Previous reports have shown thatWee1 degradation can be suppressed
by activation of the G2/M checkpoint in the presence of DNA damageHayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018(12) that also causes nucleolar disruption (6). Therefore, it is possible
that depletion of NOL11, TIF-IA, or UBF induces DNAdamage, which
in turn causes nucleolar disruption as well as Wee1 accumulation via
G2/M checkpoint activation. To test this hypothesis, we examined the
levels ofChk1phosphorylation at Ser317 (Chk1-pS317), amarker ofG2/M
checkpoint activation, and gH2A.X, a marker of DNA double-strand
breaks. The Chk1-pS317 signal was undetectable for cells with nucleolar
disruption caused by depletion of NOL11, TIF-IA, or UBF, whereas the
signal was clear for cells treated with etoposide, which induces DNA
damage and G2/M checkpoint activation (fig. S7A). Furthermore,
NOL11, TIF-IA, or UBF depletion caused nucleolar disruption but did
not increase gH2A.X signal, even though etoposide treatment increased
it (fig. S7B). In addition, neither the Chk1-pS317 signal nor the gH2A.X
signal was detectable in the Act D–treated cells with disrupted nucleoliFig. 5. Nucleolar disruption caused aberrant Wee1 accumulation and delayed mitotic entry. (A) Increased Wee1 levels caused by nucleolar disruption. HeLa cells
were treated with the indicated siRNAs and synchronized at the G2/M border. Whole-cell extracts were immunoblotted with the indicated antibodies. (B) Reduced
Wee1 turnover by nucleolar disruption. Cells were treated as Fig. 3B and examined by immunoblotting with the indicated antibodies. The number in the upper
immunoblot panels shows hours after the treatment of RO-3306. (C) Reduction of enhanced Cdk1-pY15 by MK1775 treatment. Cells treated with indicated siRNAs
were synchronized at the G2/M border. Subsequently, the cells were treated with 100 nM MK1775 for 3 hours and collected for immunoblotting using the indicated
antibodies. (D) Restoration of mitotic entry by the Wee1 inhibitor. HeLa cells were treated with or without 100 nM MK1775 at 6 hours after release from the double
thymidine block. The cells were collected at 9 hours after release from the double thymidine block, and mitotic index was examined using FACS. Values are shown as
mean ± SD, n = 3.6 of 11
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induced by nucleolar disruption, independently of the activation of the
G2/M checkpoint.
We cannot rule out the possibility that other nucleolar functions re-
lated to ribosome biogenesis cause the mitotic phenotypes found in the
cells with nucleolar disruption. Itmight be possible that the inhibition of
rRNA transcription, rather than nucleolar disruption, delaysmitotic en-
try. To check this possibility, we attempted to eliminateNOL11orTIF-IA
without disrupting the nucleolus. To that end, we transfected siRNAs for
NOL11 or TIF-IA in combination with siRNAs for RPL11, which is re-
quired for the export of pre-ribosomes with rRNA in yeast and humans
(4, 27). Blocking the export of immature ribosomes from the nucleolus
suppresses nucleolar disruption, even when rRNA transcription is
down-regulated (4). Nucleolin, a marker of the nucleolus, was trans-
located from the nucleolus after NOL11 or TIF-IA depletion, whereas
codepletion of RPL11 suppressed nucleolin translocation from the
nucleolus (fig. S8, A to C), a finding consistent with the results of our
previous work (4). Next, we examined the levels of Cdk1-pY15 and
Wee1 when the nucleolar disruption occurred or was blocked. The ly-
sates from theNOL11- or TIF-IA–depleted cells, in which the nucleolusHayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018was disrupted, showed high levels of Cdk1-pY15 andWee1, whichwere
restored to control levels by codepletion of RPL11 with NOL11 or
TIF-IA (fig. S8, D and E).
However, we still cannot exclude the possibility that mitotic pheno-
types of NOL11-, TIF-IA–, and UBF-depleted cells may be attributable
to reduced protein synthesis, considering the fact that these proteins are
involved in rRNA transcription and/or processing, inhibition of which
possibly compromises ribosome biogenesis. To ascertain whether nu-
cleolar disruption or reduced protein synthesis is the direct cause of mi-
totic phenotypes found in NOL11-, TIF-IA–, and UBF-depleted cells,
we checked whether protein synthesis was inhibited without nucleolar
disruption.We depleted rRNA processing factors such as PES1, DKC1,
or RRP5 (Fig. 6A) and examined their effect on the nucleolar morphol-
ogy (Fig. 6B), the levels of Cdk1-pY15 (Fig. 6C), mitotic entry (Fig. 6D),
and protein synthesis (Fig. 6E). Immunofluorescence staining showed
that depletion of these rRNA processing factors did not induce trans-
location of nucleolin andMYBBP1A (Fig. 6B), a finding consistent with
the results of previous studies (5, 6). In addition, depletion of rRNApro-
cessing factors did not affectWee1 levels, Cdk1-pY15 levels (Fig. 6C), or
mitotic entry after release fromdouble thymidine block (Fig. 6D), which o
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 Fig. 6. Nucleolar disruption is a leading cause of delayedmitotic entry. (A) Knockdown efficiency of siRNA for rRNA transcription factor or processing factors. HeLa cells
transfectedwith the indicated siRNAswere cultured for 48hours and immunoblottedby the indicated antibodies. (B) The alteration of nucleolar structure bydepletion of rRNA
transcription factor, not by processing factors. HeLa cells were transfected with the indicated siRNAs and cultured for 48 hours. The cells were stained with anti-nucleolin
(green) and anti-MYBBP1A (red) antibodies. DNAwas counterstained byDAPI (blue). Scale bars, 5 mm. (C) IncreasedWee1 and Cdk1-pY15 in cells with the disrupted nucleolus.
HeLa cells were synchronized at the G2/M border after siRNA transfection and immunoblotted using the indicated antibodies. (D) Delayed mitotic entry in cells with the
disrupted nucleolus. HeLa cells were treated with the indicated siRNAs and synchronized by double thymidine as the same protocol shown in Fig. 1C. Nine hours after the
release from G1/S synchronization, the cells were collected for analysis of mitotic index using flow cytometry. (E) Correlation between nuclear disruption and delayed mitotic
entry. HeLa cells were transfectedwith the indicated siRNAs and cultured for 48 hours. Thereafter, cells were incubated in the presence of HPG for 2 hours and collected for the
analysis by flow cytometry. Values are shown as means ± SD, n = 3. In parallel, the nucleolar disruption with reference to (B) and Fig. 4A and the delayed mitotic entry with
reference to (D) and Figs. 1C and 4B are shown under the graph [+, nucleolar disruption induced (top); −, nucleolar disruption not induced (top); +, delayed mitotic entry
induced (bottom); −, delayed mitotic entry not induced (bottom)]. a.u., arbitrary units; CHX, cycloheximide.7 of 11
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ruption. We examined protein synthesis by measuring the incorpora-
tion of the amino acid analog l-homopropargylglycine (HPG). The
depletion of PES1 or DKC1 reduced protein synthesis to an extent sim-
ilar to that of NOL11, TIF-IA, or UBF depletion (Fig. 6E). It was not
reduced protein synthesis, but nucleolar disruption that correlated with
mitotic phenotypes such as delayed mitotic entry and elevated Cdk1-
pY15 levels (Fig. 6, B to E), suggesting that nucleolar disruption during
interphase is the cause of mitotic phenotypes. We therefore concluded
that untimely nucleolar disruption during interphase induced improper
stabilization of Wee1, which suppressed Cdk1 activation and delayed
mitotic entry. o
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 DISCUSSION
Nucleolar structure dynamically changes during the cell cycle in higher
eukaryotes, especially during mitosis. Under normal conditions, cells
contain several nucleoli, wherein continuous rRNA transcription
occurs. Upon mitotic entry, the nucleolus disassembles in line with
the activation of Cdk1, which phosphorylates the components of rRNA
transcriptionmachinery and suppressesRNAPol I transcription (28, 29).
At the end of mitosis, the nucleolus reassembles when rRNA tran-
scription is reactivated by dephosphorylation of rRNA transcription
factors (30). Thus, nucleolar disassembly during mitosis appears to be
a programmed event because Cdk1 activity is tightly regulated during
the cell cycle. In contrast to mitotic nucleolar disassembly, a variety of
stressors such as DNAdamage, hypoxia, and starvation suppress rRNA
transcription and cause nucleolar disruption during interphase, sug-
gesting that nucleolar disruption during interphase is an acute cellular
response to stress and is induced by mechanisms distinct from those
during mitosis. We speculated that interphase nucleolar disruption
affects processes distinct from the programmed cell cycle in response
to various stimuli. We therefore proposed a link between nucleolar in-
tegrity during interphase and cell cycle progression to mitosis.
Increased inhibitory phosphorylation of Cdk1 is the
cause of delayed mitotic entry due to interphase
nucleolar disruption
We showed that mitotic entry was delayed when nucleolar disruption
was induced following the depletion of several rRNA transcription
factors (Figs. 1C and 4B). Initiation of mitosis is achieved by Cdk1 ac-
tivation, which is regulated by the accumulation of cyclin B1 and re-
moval of inhibitory phosphorylation of Cdk1 by the dual-specificity
phosphatase Cdc25 (20).
We showed that cyclin B1 accumulated normally during the cell
cycle even in the presence of nucleolar disruption (Figs. 1C, 3B, and
5B), along with a reduction in protein synthesis (Fig. 6E). We believe
that the reduction in protein synthesis was relatively mild owing to
the long half-life of ribosomes, which is 5 to 10 days under normal phys-
iological conditions (31). Therefore, severe reduction in protein synthe-
sis did not occur in our study because our siRNA-based assays were
performed between 48 and 72 hours after siRNA transfection. Addi-
tional synchronization at the G2/M border using RO-3306 showed that
cells with orwithout disrupted nucleolus contained equal levels of cyclin
B1, whereas nucleolus-disrupted cells showed increased levels of Cdk1-
pY15 (Figs. 2B and 4C) and slow nuclear translocation of cyclin B1
(Figs. 2C and 4D). Thus, interphase nucleolar disruption appears to
suppress Cdk1 activation by increasing the phosphorylation of Cdk1
without affecting cyclin B levels.Hayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018The activation of Cdk1–cyclin B is a switch-like process, as seen in
Xenopus egg extracts (32) and in human cells (33). Once the activity of
Cdk1–cyclin B exceeds the threshold, cells rapidly proceed from the G2
phase to mitosis. It was previously suggested that one of the earliest
events to exceed the threshold for mitotic entry is dephosphorylation
of Cdk1-pY15, which occurs before nuclear cyclin B translocation
(34). If phospho-Cdk1 levels increase during theG2 phase, the threshold
formitotic entry likely shifts to the state that requiresmore Cdk1–cyclin
B. We found that nucleolar disruption increased Cdk1-pY15 levels,
which persisted even after RO-3306 removal (Figs. 2B and 4C). These
results suggest that loss of nucleolar integrity delays the onset of mitosis
by raising the threshold for mitotic entry.
Aberrant accumulation of Wee1 kinase is the cause of
increased Cdk1-pY15 levels induced by nucleolar disruption
Inhibitory phosphorylation of Cdk1 is regulated by the balance between
Wee1/Myt1 kinases and Cdc25 phosphatases (20, 35). Between Wee1
andMyt1, which are responsible for inhibitory phosphorylation, Wee1
is dominant in vertebrates (36). Our results indicate that aberrant accu-
mulation ofWee1 is the cause of an increase in the inhibitory phospho-
rylation of Cdk1 when the nucleolus is disrupted during the interphase,
based on the following observations. First, Wee1 levels increased along
with those of Cdk1-pY15 during the G2 phase (Figs. 3A and 5A) when
nucleolar disruptionwas induced by siRNAs againstNOL11, TIF-IA, or
UBF. However, the fluctuation profiles of the three isoforms of Cdc25
were not consistent with changes in the levels of Cdk1 phosphorylation
(Fig. 3A and 5A). Second, up-regulation of bothWee1 and Cdk1-pY15,
found in NOL11- and TIF-IA–depleted cells, was suppressed by RPL11
depletion, which inhibited nucleolar disruption (fig. S8). Finally, treat-
ment with MK1775, a Wee1 inhibitor, abolished the Cdk1-pY15 up-
regulation and delayed mitotic entry in cells with depleted NOL11,
TIF-IA, or UBF (Fig. 5, C and D, and fig. S6, B to D).
Themolecular mechanism underlying the increase in levels ofWee1
in response to nucleolar disruption during interphase remains to be elu-
cidated. Our experimental results showed that Wee1 proteins were im-
properly stabilized and accumulated during cell cycle progression when
the nucleolus was disrupted (Figs. 3B and 5B). One possiblemechanism
is that nucleolar proteins, redistributed from the nucleolus, mediate the
stability of Wee1. This hypothesis is supported by previous studies
stating that some of the nucleolar proteins are released from the nucle-
olus in response to several cellular stresses and, among those, some elicit
cellular functions, for example, p53 activation. In general,Wee1 is down-
regulated through proteasome-dependent degradation after ubiquitina-
tion by E3 ubiquitin ligase SCF-bTrCP duringG2-M transition (37), and
theubiquitinationofWee1 is controlledby its phosphorylation.Therefore,
ubiquitin ligases, deubiquitinating enzymes, kinases, and phosphatases
in the nucleolus may regulate Cdk1 activity by controlling Wee1 levels
in response to nucleolar disruption during interphase.
Nucleolar disruption is a leading cause of delayed
mitotic entry
We found thatmitotic entrywas delayedwhen interphase nucleolar dis-
ruption was induced by the depletion of rRNA transcription factors or
treatment of low-dose Act D. However, we cannot exclude the possibil-
ity that mechanisms other than nucleolar disruption, including the ac-
tivation of the G2/M checkpoint, reduction in protein synthesis, and
inhibition of rRNA transcription, induced mitotic phenotypes.
Cells that have experiencedDNAdamage are prevented by theG2/M
checkpoint from initiating mitosis through suppression of Cdk1 (38).8 of 11
SC I ENCE ADVANCES | R E S EARCH ART I C L E
 o
n
 O
ctober 14, 201
http://advances.sciencem
ag.org/
D
ow
nloaded from
 DNA damage also induces the down-regulation of rRNA transcription,
which in turn induces nucleolar disruption (39). It is therefore possible
that depletion of rRNA transcription induces DNA damage, which in
turn suppresses Cdk1 activity and mitotic entry. However, neither
NOL11, TIF-IA, or UBF depletion nor Act D treatment increased
gH2A.X and Chk1 phosphorylation, the markers of DNA damage and
G2/M checkpoint activation, respectively (fig. S7). Delayed mitotic entry
and enhanced Cdk1-pY15 caused by nucleolar disruption are therefore
independent of G2/M checkpoint signaling pathways.
siRNAs for NOL11 or TIF-IA were transfected in combination
with siRNA for RPL11, which is required for the export of pre-
ribosomes with rRNA. Blocking the export of immature ribosomes
from the nucleolus suppresses nucleolar disruption, even when rRNA
transcription is down-regulated. We found that codepletion of RPL11
suppressed nucleolar disruption and restored the levels of Cdk1-pY15
to control levels (fig. S8, D and E). These results show that it is not the
inhibition of rRNA transcription but nucleolar disruption that elevates
Cdk1-pY15 levels. Thus, nucleolar disruption is the main cause
underlying delayed mitotic entry.
Nucleolar disruption caused by down-regulation of rRNA
transcription potentially influences several biological processes
such as ribosome biogenesis and protein synthesis. Therefore, a re-
duction in protein synthesis might cause delayed mitotic entry.
However, as we have already discussed, reduction in protein syn-
thesis was low when rRNA transcription factors were depleted (Fig.
6E). Considering that inhibition of rRNA processing increases the
levels of rRNAs within the nucleolus (5, 40), we depleted several
rRNA processing factors such as PES1, DKC1, and RRP5, which
contribute to different steps of rRNA processing. Although these
factors contribute differently to rRNA processing, nucleolar disrup-
tion did not occur, and mitosis was properly initiated (Fig. 6, B to
D). Depletion of PES1 or DKC1 reduced protein synthesis to an
extent similar to that following the depletion of NOL11, TIF-IA,
or UBF1. Together, it is unlikely that reduction in protein synthesis
is the cause of delayed mitotic entry.
In conclusion, this is the first study, to our knowledge, to provide
evidence that the maintenance of nucleolar structure is essential for
proper timing of mitotic entry. The loss of structural integrity induces
stabilization ofWee1 proteins, which induces persistent Cdk1 phospho-
rylation without activating checkpoint signals.8MATERIALS AND METHODS
Cell culture
HeLa cells were grown at 37°C in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum, penicillin (100 U/ml), and
streptomycin (100 U/ml).
Cell cycle synchronization
HeLa cells were synchronized at the G1/S boundary by using the
single thymidine block or double thymidine block methods. For
the single thymidine block, the cells were treated with 2 mM thy-
midine (Sigma-Aldrich) for 24 hours. For the double thymidine
block, single thymidine–arrested cells were replenished with fresh
medium and cultured for 8 hours. Then, the cells were treated with
2 mM thymidine and cultured further for 16 hours. To synchronize
the cells at the G2/M border, they were treated with 10 mM RO-
3306 4 to 6 hours after releasing them from the single thymidine
block, and then culturing for 12 hours.Hayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018siRNA screen and hit validation
A custom-made oligonucleotide siRNA library targeting 591 nucleolar
proteins was purchased from Invitrogen. siRNAs were transfected into
3000 HeLa cells using Lipofectamine RNAiMAX (Thermo Fisher Sci-
entific) in 96-well plates. After 72 hours, the cells were scored visually on
an inverted microscope. The first screen showed that 207 siRNAs in-
creased the number of spherical cells—the round shape is indicative of
amitotic cellularmorphology. Following the primary screen, the cellswere
transfected with positive siRNA that increased spherical cells and lysed in
RIPAbuffer [20mMtris-HCl (pH7.4), 150mMNaCl, 0.8%NP-40, 0.1%
SDS, 1% sodiumdeoxycholate, and 2mMEDTA]. The lysateswere ana-
lyzed by immunoblotting with anti–H3-pS10 antibodies. Among the 59
siRNAs that increased H3-pS10 levels, we chose NOL11 siRNA for fur-
ther characterization, as NOL11’s mitotic function remains unexplored.
Antibodies
The following antibodies were used. Rabbit polyclonal antibodies against
NOL11 (HPA022010, Sigma-Aldrich):Cdc25B (#9525,Cell SignalingTech-
nologies),Cdc25C (#4688,Cell SignalingTechnologies),Cdk1p-Y15 (#9111,
Cell Signaling Technologies), Chk1-pS317 (#12302, Cell Signaling Technol-
ogies), FBL (#2639, Cell Signaling Technologies), and gH2A.X (ab2893,
Abcam). Mouse monoclonal antibodies against a-b-actin (sc47778, Santa
Cruz Biotechnology): cyclin B1 (sc245, Santa Cruz Biotechnology), UBF
(sc13125, Santa Cruz Biotechnology), Cdk1 (sc45, Santa Cruz Bio-
technology), Wee1 (sc5285, Santa Cruz Biotechnology), tubulin (DM1A,
Millipore), nucleolin (M019-3, MBL), H3-pS10 (MABI0312, MBL),
MPM2 (05-368, Millipore), NPM (FC61991, Thermo Fisher Scientific),
andRPL11 (3A4A7,ThermoFisher Scientific). In addition, a goatpolyclonal
antibody againstTIF-IA (sc11805, SantaCruzBiotechnology)was used.The
rabbit polyclonal anti-MYBBP1A was prepared as previously described (4).
siRNA transfection
Cells were transfected with siRNAs using Lipofectamine RNAiMAX
according to the manufacturer’s protocol. All siRNAs were purchased
from Thermo Fisher Scientific. The sequences of the siRNA duplexes
were as follows: NOL11 #1, 5′-CCAAACGCAUGUGCUUUCUUACA-
GU-3′; NOL11 #2, 5′-GUCUACUUCUGGAUGCGAAUU-3′; TIF-IA
#1, 5′-CGACACCGUGGUUUCUCAUGCCAAU-3′; TIF-IA #2,
5′-GGGAUCACACCAAGCUCCUUUGACA-3′; TIF-IA #3, 5′-AG-
GAUGUCUGCUAUGUAGAUGGUAA-3′; UBF #1, 5′-UUCGG-
CUGCCUUCUUAAUCCACAUC-3 ′ ; UBF #2, 5 ′-AUCU
CACUCAGCUCUCUCUCAUAUC-3′; UBF #3, 5′-UCUCCCUG-
GAAUUUCAUCUUCUUGG-3′; PES1, 5′-CCAUUGUCAACAA-
GUUCCGUGAAUA - 3 ′ ; D K C 1 , 5 ′ - G GCCAAGAU
UAUGCUUCCAGGUGUU-3′; RRP5, 5′-GAACCAGGAGUGA-
CUGGCCUUCUUU-3′; RPL11, 5′-GCUAGAUACACUGUCA-
GAUCCUUUG-3′. Stealth RNAi siRNA Luciferase Reporter Control
(Thermo Fisher Scientific) was used as a negative control.
Immunoblotting and immunoprecipitation
The cells were lysed using the RIPA buffer supplemented with protease
inhibitor (Nacalai Tesque) and phosphatase inhibitor cocktail (Nacalai
Tesque) for 30 min on ice. The cleared lysates were separated on SDS-
polyacrylamide gels and analyzed by immunoblotting with the previ-
ously mentioned antibodies.
Immunofluorescence
The cells were grown on a poly-L-lysine–coated coverslip. For immuno-
staining, the cells were fixed with 4% paraformaldehyde (PFA) in9 of 11
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 phosphate-buffered saline (PBS; 140 mM NaCl, 2.7 mM KCl, 1.5 mM
KH2PO4, and 8.1 mM Na2HPO4) for 15 min and permeabilized with
0.2% Triton X-100 in PBS for 5 min. The fixed cells were blocked with
3% bovine serum albumin (BSA)/PBS for 1 hour at room temperature.
Then, the cells were incubated with the primary antibodies diluted with
3% BSA/PBS for 1 hour in a humidity box, stained with Alexa Fluor–
conjugated secondary antibodies for 1 hour, counterstained with DAPI
for 5 min, and mounted with VECTASHIELD (Vector Laboratories).
Images were acquired using a BioRevomicroscope (BZ-9000; Keyence)
equippedwith a 40× objective lens [PlanApochromat, numerical aperture
(NA) 0.95, Nikon] and a 100× oil objective lens (Plan Apochromat
VC, NA 1.4). Cellular counting and image cropping were performed
using ImageJ.
Classification of nucleolar morphology
To define nucleolar morphology as “without disruption” and with “nu-
cleolar disruption” in figs. S3C and S8B, we performed a blinded test.
One person prepared single-cell images and randomly numbered them.
Then, these images were classified on the basis of nucleolin localization
in a blinded manner by another person. We labeled the cells in which
nucleolinwas diffused into the nucleoplasmor localized at the nucleolar
periphery as with “nucleolar disruption” and those in which nucleolin
remained intact in the nucleolus as “without disruption.”
In addition, we analyzed the nucleolar area using ImageJ (figs. S3D,
S4, and S8C). First, a raw image was split into nucleolin and DAPI-
stained images, and the nuclear region was determined on the basis
of DAPI signals. Second, we juxtaposed the nuclear region with the nu-
cleolin image. Then, we measured the modal value of nucleolin signal
intensity and subtracted this value from the whole image of nucleolin.
Finally, we quantified the area in which nucleolin signals persisted and
considered that as the nucleolar area.
RNA purification and reverse transcription quantitative
polymerase chain reaction
RNA was isolated from cells by using the ReliaPrep RNA Cell
Miniprep System (Promega) according to the manufacturer’s in-
structions. cDNA was synthesized from total RNA using RevatraAce
reverse transcriptase (Toyobo) and random primers. The quantita-
tive polymerase chain reaction (qPCR) analysis was performed to
amplify fragments using the Thermal Cycler Dice TP800 (Takara)
and SYBR Premix Ex Taq II (Takara). The specific primer sets for
PCR amplification were 5′-GAACGGTGGTGTGTCGTTC-3′ and
5′-GCGTCTCGTCTCGTCTCACT-3′ for pre-rRNA.
Flow cytometry
The cells were fixed in 70% ethanol at −20°C. For staining intracellular
proteins, the cells were washed with 0.1% Triton X-100/PBS. Primary
antibodies were diluted with 3% BSA/PBS, with which the cells were
incubated for 1 hour, followed by incubation with secondary antibodies
for 1 hour. The cells were then stained with PI and RNase A solution
(BDBiosciences) for 15min.DNAcontent and the levels of intracellular
proteins were measured using the FACSAria II (BD Bioscience) and
analyzed using FlowJo.
Detection of newly synthesized RNA and proteins in
cultured cells
For in situ detection of nascent rRNA, the cells were incubated for
30 min in the presence of 0.5 mM 5-ethynyluridine (EU) after 48 hours
of siRNA transfection. The cells were fixed in 4% PFA/PBS for 15 minHayashi et al., Sci. Adv. 2018;4 : eaap7777 6 June 2018and permeabilized in 0.2% Triton X-100/PBS for 5 min at room tem-
perature. The samples were then processed according to the manufac-
turer’s instructions. To measure the EU signals in the nucleolus, we
counterstained the cells with an anti-UBF antibody to demarcate the
nucleolar region. The fluorescence intensity of labeled RNAs in the nu-
cleolus was measured using ImageJ. For analyzing protein synthesis, the
cells were grown in methionine- and cysteine-free medium for 1 hour
and were then treated with 25 mM HPG for 2 hours. After labeling the
proteins with HPG, the cells were washed with PBS and fixed with 70%
ethanol at −20°C. After fixation, Alexa Fluor 488 conjugation and sub-
sequent procedures were carried out as described by the supplier
(Thermo Fisher Scientific). Labeled cells were resuspended in PBS
for flow cytometry analysis on the BD FACSAria II.
Quantification and statistical analysis
Each experiment was performedmultiple times. The data from flow cy-
tometry and reverse transcription qPCRwere presented as means ± SD
from aminimum of three independent repeated experiments. For anal-
ysis of immunofluorescence data, the presented values were from sev-
eral experiments. The number of replication or the number of cells was
annotated in the figure legends.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/6/eaap7777/DC1
fig. S1. NOL11 predominantly localized in the DFC region within the nucleolus.
fig. S2. NOL11 depletion induced down-regulation of rRNA transcription and nucleolar disruption.
fig. S3. NOL11 depletion induced nucleolar disruption without undergoing mitosis.
fig. S4. Nucleolar disruption is caused by NOL11 depletion alone.
fig. S5. Treatment with Act D delayed mitotic entry.
fig. S6. The treatment with MK1775 restored the levels of Cdk1-pY15 and the nuclear
translocation of cyclin B1.
fig. S7. Depletion of NOL11, TIF-IA, or UBF and Act D treatment did not induce DNA damage
nor activate G2/M checkpoint.
fig. S8. Codepletion of RPL11 suppressed nucleolar disruption and restored the levels of Cdk1-
pY15 caused by NOL11 or TIF-IA depletion.
table S1. List of siRNAs that increased H3-pS10 levels in asynchronous cultures.REFERENCES AND NOTES
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